[go: up one dir, main page]

HUP0100098A3 - Pharmaceutical combination of active princeples, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia - Google Patents

Pharmaceutical combination of active princeples, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia

Info

Publication number
HUP0100098A3
HUP0100098A3 HU0100098A HUP0100098A HUP0100098A3 HU P0100098 A3 HUP0100098 A3 HU P0100098A3 HU 0100098 A HU0100098 A HU 0100098A HU P0100098 A HUP0100098 A HU P0100098A HU P0100098 A3 HUP0100098 A3 HU P0100098A3
Authority
HU
Hungary
Prior art keywords
dementia
tetrahydropyridins
princeples
active
pharmaceutical combination
Prior art date
Application number
HU0100098A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9714324A external-priority patent/FR2771006B1/fr
Priority claimed from FR9714322A external-priority patent/FR2771007B1/fr
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of HUP0100098A2 publication Critical patent/HUP0100098A2/hu
Publication of HUP0100098A3 publication Critical patent/HUP0100098A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU0100098A 1997-11-14 1998-11-09 Pharmaceutical combination of active princeples, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia HUP0100098A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9714324A FR2771006B1 (fr) 1997-11-14 1997-11-14 Association de principes actifs pour le traitement de la demence senile du type alzheimer
FR9714322A FR2771007B1 (fr) 1997-11-14 1997-11-14 Association de principes actifs pour le traitement de la demence senile du type alzheimer
PCT/FR1998/002384 WO1999025363A1 (fr) 1997-11-14 1998-11-09 Association de principes actifs, notamment de tetrahydropyridines et d'agents inhibiteurs de l'acetylcholinesterase, pour le traitement de la demence senile du type alzheimer

Publications (2)

Publication Number Publication Date
HUP0100098A2 HUP0100098A2 (hu) 2001-07-30
HUP0100098A3 true HUP0100098A3 (en) 2001-12-28

Family

ID=26233932

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0100098A HUP0100098A3 (en) 1997-11-14 1998-11-09 Pharmaceutical combination of active princeples, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia

Country Status (27)

Country Link
EP (1) EP1030671A1 (is)
JP (1) JP2001523642A (is)
KR (1) KR100599350B1 (is)
CN (1) CN1243540C (is)
AU (1) AU743228B2 (is)
BG (1) BG64819B1 (is)
BR (1) BR9814035A (is)
CA (1) CA2309966A1 (is)
CO (1) CO4980891A1 (is)
DZ (1) DZ2649A1 (is)
EA (1) EA003255B1 (is)
EE (1) EE04235B1 (is)
HU (1) HUP0100098A3 (is)
ID (1) ID24933A (is)
IL (2) IL136122A0 (is)
IS (1) IS5482A (is)
MY (1) MY120461A (is)
NO (1) NO20002450L (is)
NZ (1) NZ504420A (is)
OA (1) OA11464A (is)
PL (1) PL194597B1 (is)
SA (1) SA98190747B1 (is)
SK (1) SK286040B6 (is)
TR (1) TR200001262T2 (is)
TW (1) TW585766B (is)
UY (1) UY25247A1 (is)
WO (1) WO1999025363A1 (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4675103B2 (ja) * 2002-06-14 2011-04-20 富山化学工業株式会社 脳機能を改善する医薬組成物および脳機能を改善するための方法
CA2494585A1 (en) * 2002-08-07 2004-02-19 Novartis Ag Methods for the treatment of dementia based on apo e genotype
CN1520818A (zh) * 2003-02-09 2004-08-18 山东绿叶天然药物研究开发有限公司 治疗老年性痴呆的胆碱酯酶抑制剂药物组合物
CA2592605C (en) 2004-12-27 2010-12-07 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
CN106163516B (zh) 2014-01-31 2019-05-28 考格尼申治疗股份有限公司 异吲哚啉组合物和治疗神经变性疾病的方法
CN110869011B (zh) 2017-05-15 2024-01-05 考格尼申治疗股份有限公司 用于治疗神经退行性疾病的组合物
KR102224918B1 (ko) 2018-03-20 2021-03-09 (주)인벤티지랩 도네페질 및 메만틴을 포함하는 인지 장애 관련 질병의 예방 또는 치료용 약학적 복합 조성물 및 이의 제조 방법
WO2019182319A1 (ko) * 2018-03-20 2019-09-26 (주)인벤티지랩 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물의 제조 방법 및 이의 제조 방법으로 제조된 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물
CN109265391B (zh) * 2018-11-13 2021-11-19 枣庄学院 联苯多取代1,2,5,6-四氢吡啶化合物及其合成方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
US5453428A (en) * 1991-02-14 1995-09-26 The Mount Sinai School Of Medicine Of The City Of New York Method and composition for the treatment of apathy-amotivation syndrome
JPH11511732A (ja) * 1995-03-06 1999-10-12 インターニューロン ファーマシューティカルズ，インコーポレーテッド シチコリンを用いる梗塞容積の低減
FR2736053B1 (fr) * 1995-06-28 1997-09-19 Sanofi Sa Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines

Also Published As

Publication number Publication date
DZ2649A1 (fr) 2004-12-28
KR20010032099A (ko) 2001-04-16
AU743228B2 (en) 2002-01-24
SA98190747B1 (ar) 2006-11-04
IS5482A (is) 2000-05-09
CA2309966A1 (en) 1999-05-27
TW585766B (en) 2004-05-01
ID24933A (id) 2000-08-31
BG64819B1 (bg) 2006-05-31
IL136122A (en) 2006-07-05
SK286040B6 (sk) 2008-01-07
HUP0100098A2 (hu) 2001-07-30
EA200000412A1 (ru) 2000-12-25
TR200001262T2 (tr) 2001-01-22
BG104428A (en) 2001-08-31
SK7112000A3 (en) 2000-10-09
EA003255B1 (ru) 2003-02-27
KR100599350B1 (ko) 2006-07-12
PL340500A1 (en) 2001-02-12
NO20002450L (no) 2000-07-14
AU1160999A (en) 1999-06-07
CN1285742A (zh) 2001-02-28
OA11464A (en) 2003-11-18
IL136122A0 (en) 2001-05-20
EP1030671A1 (fr) 2000-08-30
NZ504420A (en) 2003-08-29
PL194597B1 (pl) 2007-06-29
MY120461A (en) 2005-10-31
NO20002450D0 (no) 2000-05-11
EE04235B1 (et) 2004-02-16
EE200000290A (et) 2001-06-15
WO1999025363A1 (fr) 1999-05-27
CO4980891A1 (es) 2000-11-27
JP2001523642A (ja) 2001-11-27
CN1243540C (zh) 2006-03-01
UY25247A1 (es) 2001-05-31
BR9814035A (pt) 2000-09-26

Similar Documents

Publication Publication Date Title
SI1123313T1 (sl) Postopki in sestavki za preventivo in zdravljenje anemije
AU2001239052A1 (en) Compositions for prevention and treatment of dementia
AP2000002010A0 (en) Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof
AU1509999A (en) Herbal drug composition for the prevention and treatment of dementia
EP0997150A4 (en) PREVENTIVE AND THERAPEUTIC COMPOSITIONS FOR NEPHROPATHIES AND HEPATITIS OF MEDICINAL ORIGIN
HUP0100098A3 (en) Pharmaceutical combination of active princeples, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia
HUP9700598A3 (en) Process for producing pharmaceutical composition useful for profilacting and treating pancreatitis
HU9800396D0 (en) Pharmaceutical composition for treating dementia
HUP0103832A3 (en) Triazolopyridines for the treatment of thrombosis disorders, pharmaceutical compositions containing the same and process for preparation thereof
IL131085A0 (en) The use of levobupivacaine or ropivacaine in treating migraine
EP1181308A4 (en) METHODS OF TREATING NEURONAL DEMENTIA ASSOCIATED WITH ATROPHY
HUP0002709A3 (en) Process for the reduction of 1-substituted -3-hydroxymethyl-4- (4-fluorophenyl)tetrahydropyridines
GB9820725D0 (en) Disinfection process and product
HK1028354A (en) Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia
IL128095A0 (en) Formulation for the treatment and/or prophylaxis of dementia
ZA989955B (en) Combination of active ingredients for the treatment of senile dementia of the alzheimer type
KR100248098B1 (en) Pharmaceutical composition for the treatment of dementia
HU0001889D0 (en) Pharmaceutical composition for treating migraine
HU9900295D0 (en) Combined products for treating the desease of plant pathogen-micro-organism and for preventing the contamination
HU9802515D0 (en) Pharmaceutical compositions for treating allergias and process for producing former compositions
HU9904440D0 (en) Pharmaceutical composition for the prevention and the treatment of fungus-infected and process producing the agents
EP1173159A4 (en) COMPOSITION AND METHOD FOR TREATING COLIC
HK1022648A (zh) 治疗偏头痛的药物
SI0918521T1 (en) Formulation for the treatment and/or prophylaxis of dementia
GB9930342D0 (en) Improved composition and method for the treatment of drug abuse

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished